TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
ACHIM Biotherapeutics AB
Closing information (x1000 DKK)
Closing information | 2023/06 | 2022/06 | 2021/06 |
Turnover | 589 | 712 | |
Financial expenses | 0 | 0 | |
Earnings before taxes | 70 | 254 | |
EBITDA | 70 | 254 | |
Total assets | 435 | 472 | |
Current assets | 435 | 472 | |
Current liabilities | 84 | 176 | |
Equity capital | 350 | 295 | |
- share capital | 104 | 37 | |
Employees (average) | 1 | 1 | 1 |
Financial ratios
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Solvency | 80.5% | 62.5% | |
Turnover per employee | 589 | 712 | |
Profit as a percentage of turnover | 11.9% | 35.7% | |
Return on assets (ROA) | 16.1% | 53.8% | |
Current ratio | 517.9% | 268.2% | |
Return on equity (ROE) | 20.0% | 86.1% | |
Change turnover | -87 | 136 | |
Change turnover % | -100% | -13% | 24% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2023/06 | 2022/06 | 2021/06 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.